INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Results

71,097 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
17
LH
Lee Rachel H.Director
APLDApplied Digital Corp.
Grant or award
A—
14.4K sh
Nov 4, 2026Nov 6, 2026
Page 28 of 1778
← PrevNext →
traded Nov 4, 2026
+2d
SEC Form 4

Evidence

17
KR
Kasnavi RezaEVP, Chief Ops & Tech Officer
SWKSSKYWORKS SOLUTIONS, INC.
Grant or award
A—
14.2K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

16
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$293K
520 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

16
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$407K
720 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

16
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$311K
539 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

16
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$262K
462 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

16
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$321K
562 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

16
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$337K
560 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

16
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$334K
585 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

16
DR
Dury Michael R.CEO of Merchants Capital
MBINMerchants Bancorp
Gift
G—
9,500 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

16
WD
Wheeler Bryan DEVP & Chief Merchandising Ofc
DGDOLLAR GENERAL CORP
Tax withholding
F$233K
1,647 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

16
SW
Sims Beth WGeneral Counsel and Corp. Sec.
FBKFB Financial Corp
Gift
G—
500 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

16
FR
Foxx Anthony RDirector
NXPINXP Semiconductors N.V.
Gift
G—
188 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

16
ZS
Zang SaulDirector
IRSIRSA INVESTMENTS & REPRESENTATIONS INC
Other acquisition or disposition
J—
134.8K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

16
BN
Bendersky NicolasDirector
IRSIRSA INVESTMENTS & REPRESENTATIONS INC
Other acquisition or disposition
J—
2,392 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

16
MH
Machek HowardChief Accounting Officer
CENTCENTRAL GARDEN & PET CO
Tax withholding
F$191K
4,594 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

16
MH
Machek HowardChief Accounting Officer
CENTCENTRAL GARDEN & PET CO
Option exercise
M$175K
4,968 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

16
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise
M$953K
1,478 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

16
FN
Fleming Ned N. IVSenior VP - Strategy & Bus Dev, Member of 10% owner group
ROADConstruction Partners, Inc.
Tax withholding
F$246K
2,482 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

16
QM
Quenzer MichaelEVP, Chief Financial Officer
LIILENNOX INTERNATIONAL INC
Option exercise
M$177K
635 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

16
LA
Love Scott AEVP - Wealth Management
WSBCWESBANCO INC
Option exercise
M$58K
1,500 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

16
BL
Bogart Stacy LSVP-Chief Legal Officer
WGOWINNEBAGO INDUSTRIES INC
Option exercise
M$133K
4,323 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

16
RG
Romanzi Kenneth G.Director, Chief Executive Officer
NATRNATURES SUNSHINE PRODUCTS INC
Tax withholding
F$193K
15.0K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

16
DK
Dai KunDirector, Chief Executive Officer
UXINUxin Ltd
Open-market purchase · 10b5-1 plan
BUY$7,216
8,307 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

16
CB
Crowl BenChief Lending Officer, EVP
FSBWFS Bancorp, Inc.
Tax withholding
F$116K
2,604 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

16
PM
Patten Jarrod MDirector
MSTRStrategy Inc
Option exercise
M$87K
4,750 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

16
QM
Quenzer MichaelEVP, Chief Financial Officer
LIILENNOX INTERNATIONAL INC
Disposition to issuer
D$189K
529 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

16
CR
Corbin Charles R. Jr.See Remarks
HGVHilton Grand Vacations Inc.
Option exercise · 10b5-1 plan
M$1.20M
31.4K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

16
AJ
Anderson JudyVP/CFO
WEYSWEYCO GROUP INC
Tax withholding
F$59K
906 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

15
TG
Thiel Frederick GDirector, Chief Executive Officer
MARAMARA Holdings, Inc.
Tax withholding
F$435K
67.7K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

15
ID
Ishaug Anthony DCHIEF FINANCIAL OFFICER
WINAWINMARK CORP
Option exercise
M$477K
3,800 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

15
BJ
Baughman Michael JExec VP, CFO & CAO
EMREMERSON ELECTRIC CO
Tax withholding
F$325K
1,937 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

15
PJ
Peters William JDirector, CFO, EVP & TREASURER
AMPHAmphastar Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$448K
16.0K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

15
KD
Krulik DouglasCAO and Interim CFO
PETSPETMED EXPRESS INC
Tax withholding
F$2,898
2,435 sh
Oct 30, 2026Nov 6, 2026
traded Oct 30, 2026
+7dSEC Form 4

Evidence

15
KT
Kelley Shannon TGeneral Counsel
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$431K
1,077 sh
Nov 6, 2026Nov 6, 2026
traded Nov 6, 2026
+0dSEC Form 4

Evidence

15
OS
Orn Jonsson SigurgeirChief Technology Officer
BETRBetter Home & Finance Holding Co
Option exercise
M—
3,906 sh
Nov 1, 2026Nov 6, 2026
traded Nov 1, 2026
+5dSEC Form 4

Evidence

15
PA
Paeger AxelDirector
AVXLANAVEX LIFE SCIENCES CORP.
Grant or award
A—
50.0K sh
Nov 3, 2026Nov 6, 2026
traded Nov 3, 2026
+3dSEC Form 4

Evidence

15
KT
Kellmeyer TerrieDirector, President and CEO
AVXLANAVEX LIFE SCIENCES CORP.
Grant or award
A—
200.0K sh
Nov 3, 2026Nov 6, 2026
traded Nov 3, 2026
+3dSEC Form 4

Evidence

15
DO
Donhauser Peter D.O.Director
AVXLANAVEX LIFE SCIENCES CORP.
Grant or award
A—
50.0K sh
Nov 3, 2026Nov 6, 2026
traded Nov 3, 2026
+3dSEC Form 4

Evidence

15
KR
Krishnan Ram R.Executive Vice Pres & COO
EMREMERSON ELECTRIC CO
Tax withholding
F$605K
3,609 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence